Topical platelet-rich plasma as a possible treatment for olfactory dysfunction-A randomized controlled trial.

Alexander DuffyBita R NaimiEmily GarveyStephanie HunterAyan KumarChase KahnDouglas FarquharGlen E D'SouzaNancy RawsonPamela DaltonElina ToskalaMindy RabinowitzMarc RosenGurston NyquistDavid Rosen

Published in: International forum of allergy & rhinology (2024)

This study is the first to describe topical PRP as a safe, experimental treatment for OD in humans. PRP may impact odor identification in post-COVID-19 OD patients, although the lack of difference in total BSIT scores highlights the need for further study.

Keyphrases

platelet rich plasma
sars cov
end stage renal disease
newly diagnosed
ejection fraction
oxidative stress
prognostic factors
combination therapy
patient reported outcomes